The Board of Directors of Alterity Therapeutics (the “Company”) sets high standards for the Company’s employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the Company’s business. To fulfill its responsibilities and to discharge its duty, the Board of Directors follows the procedures and standards that are set forth in these guidelines. These guidelines are subject to modification from time to time as the Board of Directors deems appropriate in the best interests of the Company or as required by applicable laws and regulations.
Governance Documents
September 26, 2024 | Corporate-Governance-Statement-2024 | 161 KB | |
November 21, 2023 | Incentive-Based Compensation Recovery Policy | 89 KB | |
November 16, 2022 | Alterity Therapeutics Constitution (Amended November 2022) | 445 KB | |
September 13, 2022 | Communication and Disclosure Policy | 130 KB | |
September 13, 2022 | Anti-Bribery and Anti-Corruption Policy | 150 KB | |
September 13, 2022 | Securities Trading Policy | 182 KB | |
April 29, 2020 | Board Charter | 1 MB | |
May 15, 2019 | Whistle Blower Policy | 320 KB | |
May 15, 2019 | Diversity Policy | 197 KB | |
November 23, 2020 | 2018 ADS Plan (as amended) | 100 KB | |
November 23, 2020 | 2004 ASX Plan (as amended) | 52 KB |